SARC 014: A PHASE I STUDY OF RAPAMYCIN AND R1507, A RECOMBINANT HUMAN MONOCLONAL ANTIBODY TO THE INSULIN-LIKE GROWTH FA CTOR-1 RECEPTOR FOR THE TREATMENT OF PATIENTS WITH…

Phase I Trial Designs Phase I Trial Designs Jud Blatchford, PhD BIOM 6649 – Clinical Trials April 9th, 2015 Table of Contents Orientation Introduction Components of a Phase…

Slide 1 1 Preliminary Analysis Of Phase I, First-In-Human, Cathepsin Activated Tumor Imaging Probe Brian Brigman November 1, 2013 1 All Rights Reserved, Duke Medicine 2011…

Phase I Trial Designs Phase I Trial Designs Jud Blatchford, PhD Colorado School of Public Health January 30th, 2013 Table of Contents Orientation Introduction Components…

Slide 1Phase I dose escalation studies in Oncology: a call for on-study safety and flexibility Bill Mietlowski, Biometrics and Data Management, Novartis Oncology KOL Adaptive…

SK Sandhu1,2, R Wenham3, G Wilding4, M McFadden5, L Sun5, C Toniatti5, M Stroh5, C Carpenter5, J de-Bono1,2, WR Schelman4 First in Human Trial of a Poly(ADP-ribose) Polymerase…

Dose finding designs driven by immunotherapy outcomes Dose finding designs driven by immunotherapy outcomes with Application to a metastatic melanoma phase I trial Elizabeth…